Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $54,600 - $73,150
-700 Closed
0 $0
Q3 2020

Oct 28, 2020

BUY
$95.51 - $112.95 $66,857 - $79,065
700 New
700 $289,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Cozad Asset Management Inc Portfolio

Follow Cozad Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cozad Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cozad Asset Management Inc with notifications on news.